Microbiotica heads to the clinic with Europe’s largest microbiome financing

Microbiotica has the cash it needs to get the first clinical data from its microbiome therapies after raising Europe’s largest venture round for a microbiome company.

The Cambridge, U.K.-based biotech said Monday that it raised £50 million ($65.8 million) in a series B round co-led by Flerie Invest and Tencent Holdings Ltd. The company had previously raised about $15 million across two venture financings and was bolstered by a 2018 deal with the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) that had a total value of up to $534 million. The deal’s upfront payment was undisclosed. ...